FDA Panel Recommends Easier Access to Peptide Therapies

An advisory panel to the Food and Drug Administration (FDA) has voted in favor of allowing easier access to popular peptide therapies, recommending that specialized pharmacies be permitted to produce them, despite opposing recommendations from agency scientists.